The frequency of T-regulatory cells (CD4+CD25+Foxp3+, Tregs) declined also in the advanced MASLD patients (3.57%) compared to the early stage disease (5.16%). This evidence concerns the gene FOXP3 and metabolic dysfunction-associated steatotic liver disease.